Sivextro
Product Images NDC 72000-320

4 FDA label images from Nabriva Therapeutics Us, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sivextro (NDC 72000-320). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nabriva Therapeutics Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Sivextro Nabriva 01

Sivextro Nabriva 01
Chemical structure diagram of the active ingredient in SIVEXTRO by Nabriva Therapeutics US, Inc. The structure features a complex arrangement including a fluorophenyl group, triazole ring, and phosphonic acid moiety.*
FDA Label Image

Sivextro Nabriva 02

Sivextro Nabriva 02
SIVEXTRO (tedizolid phosphate) tablets packaging label showing 200 mg strength per tablet. The label states a quantity of 30 tablets, the NDC 72000-310-30, and indicates the product is Rx only. Label shows manufacturer as Nabriva Therapeutics US, Inc., Fort Washington, PA, and notes formulation in Canada. Storage and dosage instructions are included on the label.*
FDA Label Image

Sivextro Nabriva 03

Sivextro Nabriva 03
Packaging label for Sivextro (tedizolid phosphate) tablets, 200 mg per tablet, containing 6 tablets. The label indicates prescription use only (Rx only) and shows the NDC number 72000-310-06. The labeler is Nabriva Therapeutics US, Inc. The label includes storage instructions, operating instructions, and barcode areas.*
FDA Label Image

Sivextro Nabriva 04

Sivextro Nabriva 04
Packaging label for SIVEXTRO (tedizolid phosphate) for injection, 200 mg per vial, intended for intravenous infusion. The label indicates a package containing 10 single-dose vials, labeled Rx only and sterile. It includes storage instructions and incompatibility warnings with certain solutions. The labeler is Nabriva Therapeutics US, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.